Bayer Ascensia recall marked "class I"
This article was originally published in Clinica
Executive Summary
The FDA has slapped a class 1 label - the most serious category - on Bayer Healthcare's recall of its Ascensia Contour blood glucose monitoring system. The company initiated the recall after discovering 16 of the glucose meters, distributed in Canada, had not been adjusted to display the correct measure for Canadian users.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.